INIS
engineering
100%
proteins
100%
detection
100%
antibodies
100%
diagnostic techniques
50%
viruses
50%
values
25%
applications
25%
production
25%
design
25%
cost
25%
inhibition
25%
molecules
25%
stability
25%
management
25%
signals
25%
binders
25%
therapy
25%
accounting
25%
infectious diseases
25%
luciferase
25%
coronaviruses
25%
covid-19
25%
Keyphrases
Nanobody
100%
SARS-CoV-2 Neutralization
100%
SARS-CoV-2 Detection
100%
Diagnostic Tool
14%
Multi-modular
14%
SARS-CoV-2 Spike Protein
14%
Conventional Antibodies
14%
Small Protein
14%
High Stability
7%
Binding Site
7%
Unique Properties
7%
Low-cost Production
7%
Signaling Molecules
7%
IC50 Value
7%
Rapid Detection
7%
Potent Inhibitor
7%
New Therapeutics
7%
Peptide Variants
7%
Patient-specific Therapy
7%
New Diagnostics
7%
Respiratory Viruses
7%
Structure-guided
7%
Therapeutic Tool
7%
COVID-19 Pandemic
7%
COVID-19
7%
Emerging Infectious Diseases
7%
Alpha Variant
7%
Subnanomolar
7%
Emerging Viruses
7%
High Potency
7%
Protein Binders
7%
Outbreak Management
7%
Delta Variant
7%
Multiple Modules
7%
SARS-CoV-2 Inhibition
7%
Single-domain Antibody
7%
Beta Variant
7%
Omicron Variant
7%
Antigenic Drift
7%
Nanoluciferase
7%
Coronavirus Inhibitors
7%
Camelid Antibody
7%
Immunology and Microbiology
Neutralization
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Single-Domain Antibody
100%
Immunology
20%
Spike
13%
COVID-19
6%
Epitope
6%
Infectious Disease
6%
IC50
6%
Coronavirinae
6%
Respiratory Virus
6%
Biological Product
6%
Emerging Viruses
6%
Omicron Coronavirus Variant
6%
Antigenic Drift
6%
Camelid
6%
Wild Type
6%
Binding Site
6%
Pharmacology, Toxicology and Pharmaceutical Science
SARS Coronavirus
100%
Nanobody
100%
Respiratory Virus
6%
Pandemic
6%
Infection
6%
Binding Site
6%
Biological Product
6%
Antivirus Agent
6%
Coronavirinae
6%
Camelid
6%
Delta Variant
6%
Epitope
6%
IC50
6%
Luciferase
6%
Biochemistry, Genetics and Molecular Biology
SARS Coronavirus
100%
Single-Domain Antibody
100%
Spike
13%
Wild Type
6%
Binding Site
6%
IC50
6%
Camelid
6%
Respiratory Virus
6%
Coronavirinae
6%
Luciferase
6%